A new frontier in hearing loss treatment MSC-derived exosomes represent a novel, minimally invasive strategy for treating sensorineural hearing loss.

Despite this, long-range, paracrine Wnt signaling has been observed, and one explanation is that they stick to the outside of cell packages called exosomes.

TAMPA, FL / ACCESSWIRE / August 16, 2023 / EV Biologics Corp, OTC PINK:YECO, today announced that it has completed production of a next-generation, "Gen-2", MSC exosome-based therapeutic product ...

DynaCord is a leading Exosome biotechnology research and manufacturer, specializing in the development and production of Umbilical Cord Derived Mesenchymal Stem Cell (MSC) Exosome products.

Clinically, exosomes show promise as therapeutic agents themselves (e.g., MSC-exosomes for anti-inflammatory effects) and as drug delivery vehicles, with ongoing clinical trials exploring these ...